COVID-19 is Impact on Nuclear Medicine Market to Reach Valuation of $8.2 Billion by 2022 | Mallinckrodt plc., General Electric Co. (healthcare division), Medtronic, Inc.

According to a new report published by Allied Market Research, titled, "Nuclear Medicine Market by Type (Diagnostic, Therapeutic), Modality (SPECT, PET, Alpha-emitters, Beta-emitters, Brachytherapy), Application (Oncology, Cardiology, Neurology, Thyroid), Procedures (Central Nervous System, Endocrine, Skeletal, Gastrointestinal, Genito-urinary, Pulmonary) and End User (Hospitals and diagnostic centers, Research institutes) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022" The report has offered an all-inclusive analysis of the global Nuclear Medicine Market taking into consideration all the crucial aspects like growth factors, constraints, market developments, top investment pockets, future prospects, and trends. At the start, the report lays emphasis on the key trends and opportunities that may emerge in the near future and positively impact the overall industry growth.

The global radiopharmaceuticals market is expected to garner $8,207.5 million by 2022.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/1131

Key drivers that are propelling the growth of the market included in the report. Additionally, challenges and restraining factors that are likely to curb the growth of the market are put forth by the analysts to prepare the manufacturers for future challenges in advance.

The report presents in-depth insights into each of Type, Application, Procedures, and End User. verticals along with annual forecasts to 2027. The report provides revenue forecast with sales, and sales growth rate of the global Nuclear Medicine market. The forecasts are also provided with respect to the Type, Application, Procedures, and End User segments of the market. The forecasts are issued to understand the future outlook and prospects of the industry.

The market is evaluated based on its regional penetration, explaining the performance of the market in each regional market covering provinces such as North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/1131

Top 10 leading companies in the global Nuclear Medicine market are analyzed in the report along with their business overview, operations, financial analysis, SWOT profile and Nuclear Medicine products and services. The key players operating in the global Nuclear Medicine industry include Mallinckrodt plc., General Electric Co. (healthcare division), Medtronic, Inc., Bayer AG, Cardinal Health, Inc., Lantheus Medical Imaging, Inc., and IBA Group

Latest news and industry developments in terms of market expansions, acquisitions, growth strategies, joint ventures and collaborations, product launches, market expansions etc. are included in the report.

Key Benefits:

• The report provides a qualitative and quantitative analysis of the current Nuclear Medicine market trends, forecasts, and market size from 2020 to 2027 to determine the prevailing opportunities.
• Porter's Five Forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make strategic business decisions and determine the level of competition in the industry.
• Top impacting factors & major investment pockets are highlighted in the research.
• The major countries in each region are analyzed and their revenue contribution is mentioned.
• The market report also provides an understanding of the current position of the market players active in the Nuclear Medicine industry.

Highlights of the Report:

• Competitive landscape of the Nuclear Medicine Market.
• Revenue generated by each segment of the Nuclear Medicine market by 2027.
• Factors expected to drive and create new opportunities in the Nuclear Medicine industry.
• Strategies to gain sustainable growth of the market.
• Region that would create lucrative business opportunities during the forecast period.
• Top impacting factors of the Nuclear Medicine market.

Access Full Report Summary: https://www.alliedmarketresearch.com/nuclear-medicine-radiopharmaceuticals-market

Contact:

David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About Us

Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.

This release was published on openPR.